256 related articles for article (PubMed ID: 31023615)
1. A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma.
Piñero F; Vazquez M; Baré P; Rohr C; Mendizabal M; Sciara M; Alonso C; Fay F; Silva M
Ann Hepatol; 2019; 18(3):480-487. PubMed ID: 31023615
[TBL] [Abstract][Full Text] [Related]
2. Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma.
Zheng R; Wang G; Pang Z; Ran N; Gu Y; Guan X; Yuan Y; Zuo X; Pan H; Zheng J; Wang F
Cancer Med; 2020 Jun; 9(12):4232-4250. PubMed ID: 32281295
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease.
Ponziani FR; Bhoori S; Castelli C; Putignani L; Rivoltini L; Del Chierico F; Sanguinetti M; Morelli D; Paroni Sterbini F; Petito V; Reddel S; Calvani R; Camisaschi C; Picca A; Tuccitto A; Gasbarrini A; Pompili M; Mazzaferro V
Hepatology; 2019 Jan; 69(1):107-120. PubMed ID: 29665135
[TBL] [Abstract][Full Text] [Related]
4.
Chen T; Ding R; Chen X; Lu Y; Shi J; Lü Y; Tang B; Zhang W; Ye C; Yuan M; Yang Z
Bioengineered; 2021 Dec; 12(1):8233-8246. PubMed ID: 34592890
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic potential of gut microbiome for early hepatitis B virus-related hepatocellular carcinoma.
Tang Y; Zhou H; Xiang Y; Cui F
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e167-e175. PubMed ID: 33208683
[TBL] [Abstract][Full Text] [Related]
6. Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 -/- mouse model.
Behary J; Raposo AE; Amorim NML; Zheng H; Gong L; McGovern E; Chen J; Liu K; Beretov J; Theocharous C; Jackson MT; Seet-Lee J; McCaughan GW; El-Omar EM; Zekry A
BMC Microbiol; 2021 Apr; 21(1):113. PubMed ID: 33858327
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma.
Ren Z; Li A; Jiang J; Zhou L; Yu Z; Lu H; Xie H; Chen X; Shao L; Zhang R; Xu S; Zhang H; Cui G; Chen X; Sun R; Wen H; Lerut JP; Kan Q; Li L; Zheng S
Gut; 2019 Jun; 68(6):1014-1023. PubMed ID: 30045880
[TBL] [Abstract][Full Text] [Related]
8. Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC.
Sydor S; Best J; Messerschmidt I; Manka P; Vilchez-Vargas R; Brodesser S; Lucas C; Wegehaupt A; Wenning C; Aßmuth S; Hohenester S; Link A; Faber KN; Moshage H; Cubero FJ; Friedman SL; Gerken G; Trauner M; Canbay A; Bechmann LP
Clin Transl Gastroenterol; 2020 Mar; 11(3):e00131. PubMed ID: 32352707
[TBL] [Abstract][Full Text] [Related]
9. Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis.
Grąt M; Wronka KM; Krasnodębski M; Masior Ł; Lewandowski Z; Kosińska I; Grąt K; Stypułkowski J; Rejowski S; Wasilewicz M; Gałęcka M; Szachta P; Krawczyk M
Transplant Proc; 2016 Jun; 48(5):1687-91. PubMed ID: 27496472
[TBL] [Abstract][Full Text] [Related]
10. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy.
Bajaj JS; Betrapally NS; Hylemon PB; Heuman DM; Daita K; White MB; Unser A; Thacker LR; Sanyal AJ; Kang DJ; Sikaroodi M; Gillevet PM
Hepatology; 2015 Oct; 62(4):1260-71. PubMed ID: 25820757
[TBL] [Abstract][Full Text] [Related]
11. Circulating Microbiota-Based Metagenomic Signature for Detection of Hepatocellular Carcinoma.
Cho EJ; Leem S; Kim SA; Yang J; Lee YB; Kim SS; Cheong JY; Cho SW; Kim JW; Kim SM; Yoon JH; Park T
Sci Rep; 2019 May; 9(1):7536. PubMed ID: 31101866
[TBL] [Abstract][Full Text] [Related]
12. Characterization of gut microbiota in patients with primary hepatocellular carcinoma received immune checkpoint inhibitors: A Chinese population-based study.
Li L; Ye J
Medicine (Baltimore); 2020 Sep; 99(37):e21788. PubMed ID: 32925716
[TBL] [Abstract][Full Text] [Related]
13. Dysbiosis of the gut microbiome in elderly patients with hepatocellular carcinoma.
Zhang W; Xu X; Cai L; Cai X
Sci Rep; 2023 May; 13(1):7797. PubMed ID: 37179446
[TBL] [Abstract][Full Text] [Related]
14. Apelin and the gut microbiome: Potential interaction in human MASLD.
Effenberger M; Grander C; Hausmann B; Enrich B; Pjevac P; Zoller H; Tilg H
Dig Liver Dis; 2024 Jun; 56(6):932-940. PubMed ID: 38087672
[TBL] [Abstract][Full Text] [Related]
15. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation.
Bajaj JS; Hylemon PB; Ridlon JM; Heuman DM; Daita K; White MB; Monteith P; Noble NA; Sikaroodi M; Gillevet PM
Am J Physiol Gastrointest Liver Physiol; 2012 Sep; 303(6):G675-85. PubMed ID: 22821944
[TBL] [Abstract][Full Text] [Related]
16. Gut microbial signatures of patients with primary hepatocellular carcinoma and their healthy first-degree relatives.
Feng J; Wu Y; Dai P; Wang D; Liu L; Chai B
J Appl Microbiol; 2023 Oct; 134(10):. PubMed ID: 37777841
[TBL] [Abstract][Full Text] [Related]
17. A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinoma.
Effenberger M; Waschina S; Bronowski C; Sturm G; Tassiello O; Sommer F; Zollner A; Watschinger C; Grabherr F; Gstir R; Grander C; Enrich B; Bale R; Putzer D; Djanani A; Moschen AR; Zoller H; Rupp J; Schreiber S; Burcelin R; Lass-Flörl C; Trajanoski Z; Oberhuber G; Rosenstiel P; Adolph TE; Aden K; Tilg H
Hepatol Commun; 2023 Jul; 7(7):. PubMed ID: 37314752
[TBL] [Abstract][Full Text] [Related]
18. Human microbiome is a diagnostic biomarker in hepatocellular carcinoma.
Rao BC; Lou JM; Wang WJ; Li A; Cui GY; Yu ZJ; Ren ZG
Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):109-115. PubMed ID: 32037278
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic sensitivity of hepatocellular carcinoma imaging and its application to non-cirrhotic patients.
Lin MT; Chen CL; Wang CC; Cheng YF; Eng HL; Wang JH; Chiu KW; Lee CM; Hu TH
J Gastroenterol Hepatol; 2011 Apr; 26(4):745-50. PubMed ID: 21418303
[TBL] [Abstract][Full Text] [Related]
20. Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma.
Lapidot Y; Amir A; Nosenko R; Uzan-Yulzari A; Veitsman E; Cohen-Ezra O; Davidov Y; Weiss P; Bradichevski T; Segev S; Koren O; Safran M; Ben-Ari Z
mSystems; 2020 Jun; 5(3):. PubMed ID: 32546668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
